Tatjana Zaharov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tatjana Zaharov has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alex Christian Yde Nielsen
Department of Microbiology Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark
1 shared publication - Anja Poulsen
Department of Pediatrics and Adolescent Health Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark
1 shared publication Anne Mette Plomgaard
Department of Neonatology Copenhagen University Hospital, Hvidovre Hvidovre Denmark
1 shared publication- Bo Mølholm Hansen
Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Hilleroed, Denmark
1 shared publication - Bojko Bjelakovic
Clinic of Pediatrics, Clinical Center, Niš, Serbia
1 shared publication - Branislav Milovanović
Faculty of Physical Chemistry, University of Belgrade, Studentski Trg 12-16, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Wiley in Acta Paediatrica
Postnatally Acquired Cytomegalovirus Infection in Extremely Premature Infants: A Prospective Observational Cohort Study
Aim: Postnatally acquired cytomegalovirus (pCMV) infection may cause severe disease in extremely preterm infants, but its clinical significance remains uncertain. We investigated the incidence, timing, disease burden, and diagnostic performance of saliva screening. Method: In this prospective cohort study, infants born at < 28 weeks of gestation or with a birth weight < 1200 g to CMV‐seropositive mothers and fed untreated mothers' own milk underwent weekly saliva and urine CMV polymerase chain reaction testing. Outcomes before discharge and at 2 years corrected age were compared between CMV‐positive and CMV‐negative infants. Results: Forty‐five infants were included, of whom 20 (44%) acquired pCMV. CMV was detected at a median age of 44 days in saliva, 50 days in urine, and 55 days in blood. Two (10%) infected infants developed severe disease requiring antiviral treatment. No significant differences were observed in neonatal morbidity, hospitalisation duration, mortality, or neurodevelopmental outcomes. Saliva PCR demonstrated a sensitivity of 86% and a specificity of 93%. Conclusion: pCMV transmission was common in extremely preterm infants receiving mothers' own milk, but clinically significant disease occurred in only a minority of infected infants. Saliva‐based screening demonstrated acceptable diagnostic performance and may facilitate early recognition and targeted management of clinically significant pCMV infection.
- 25 September 2026
- Published by Wiley in Acta Paediatrica
Open AccessPostnatally Acquired Cytomegalovirus Infection in Extremely Premature Infants: A Prospective Observational Cohort Study
Aim: Postnatally acquired cytomegalovirus (pCMV) infection may cause severe disease in extremely preterm infants, but its clinical significance remains uncertain. We investigated the incidence, timing, disease burden, and diagnostic performance of saliva screening. Method: In this prospective cohort study, infants born at < 28 weeks of gestation or with a birth weight < 1200 g to CMV‐seropositive mothers and fed untreated mothers' own milk underwent weekly saliva and urine CMV polymerase chain reaction testing. Outcomes before discharge and at 2 years corrected age were compared between CMV‐positive and CMV‐negative infants. Results: Forty‐five infants were included, of whom 20 (44%) acquired pCMV. CMV was detected at a median age of 44 days in saliva, 50 days in urine, and 55 days in blood. Two (10%) infected infants developed severe disease requiring antiviral treatment. No significant differences were observed in neonatal morbidity, hospitalisation duration, mortality, or neurodevelopmental outcomes. Saliva PCR demonstrated a sensitivity of 86% and a specificity of 93%. Conclusion: pCMV transmission was common in extremely preterm infants receiving mothers' own milk, but clinically significant disease occurred in only a minority of infected infants. Saliva‐based screening demonstrated acceptable diagnostic performance and may facilitate early recognition and targeted management of clinically significant pCMV infection.
- Open Access
- 15 July 2024
- Published by Wiley
Chronic lung disease after hospitalization with adenovirus or respiratory syncytial virus
Background : Studies have shown a high risk of interstitial lung disease after hospitalization with adenovirus (AdV) and a high risk of asthma after hospitalization with respiratory syncytial virus (RSV) Objective : To clarify to what extent children hospitalized with respiratory tract infection caused by AdV or RSV develop pulmonary disease Design : Register-based cohort study Methods : Data on infections with AdV and RSV were coupled to data on asthma, asthma medication bronchiectasia, and interstitial lung disease including bronchiolitis obliterans during a follow-up time of 15 – 20 years. An age-matched control group was also generated. The risks of subsequent lung disease and/or having received asthma medication and hazard ratios (HRs) for asthma between the index groups and the control group were computed Findings : In total 4704 children were included. Less than 5 cases of interstitial lung disease or bronchiectasia were found in any group. After hospitalization with AdV or RSV the risk of acquiring an asthma diagnosis or having received asthma medication during follow up was 29% and 65%, respectively for AdV, and 22% and 51%, respectively for RSV; corresponding to adjusted HRs of 2.16 (0.92-5.07), 2.60 (1.57-4.31), 2.87 (2.30-3.58), and 2.37 (2.07-2.71), respectively Conclusion : We could not confirm an increased risk of interstitial lung disease after infection with AdV. However, there is a considerable risk of asthma after hospitalization with AdV or RSV and with respect to RSV the risk is higher than previously reported as expressed by the fraction having received asthma medication during follow up
- 15 July 2024
- Published by Wiley
Open AccessChronic lung disease after hospitalization with adenovirus or respiratory syncytial virus
Background : Studies have shown a high risk of interstitial lung disease after hospitalization with adenovirus (AdV) and a high risk of asthma after hospitalization with respiratory syncytial virus (RSV) Objective : To clarify to what extent children hospitalized with respiratory tract infection caused by AdV or RSV develop pulmonary disease Design : Register-based cohort study Methods : Data on infections with AdV and RSV were coupled to data on asthma, asthma medication bronchiectasia, and interstitial lung disease including bronchiolitis obliterans during a follow-up time of 15 – 20 years. An age-matched control group was also generated. The risks of subsequent lung disease and/or having received asthma medication and hazard ratios (HRs) for asthma between the index groups and the control group were computed Findings : In total 4704 children were included. Less than 5 cases of interstitial lung disease or bronchiectasia were found in any group. After hospitalization with AdV or RSV the risk of acquiring an asthma diagnosis or having received asthma medication during follow up was 29% and 65%, respectively for AdV, and 22% and 51%, respectively for RSV; corresponding to adjusted HRs of 2.16 (0.92-5.07), 2.60 (1.57-4.31), 2.87 (2.30-3.58), and 2.37 (2.07-2.71), respectively Conclusion : We could not confirm an increased risk of interstitial lung disease after infection with AdV. However, there is a considerable risk of asthma after hospitalization with AdV or RSV and with respect to RSV the risk is higher than previously reported as expressed by the fraction having received asthma medication during follow up
- 14 November 2009
- Published by Springer Nature in Pediatric Cardiology
- Vol. 31 (2) , 188-194
Heart Rate Variability in Children with Exercise-Induced Idiopathic Ventricular Arrhythmias
Ventricular arrhythmias (VAs) are common pediatric rhythm disorders requiring comprehensive laboratory evaluation. Although usually idiopathic, implying a benign character and favorable prognosis, the initial clinical approach is still not established in all cases. Considering their prognostic significance, exercise-induced (precipitated or aggravated) VAs usually require additional diagnostics, treatment, and follow-up. A number of reports have presented experimental and clinical evidence that increased sympathetic activity can initiate, or at least facilitate, VAs. Recent data highlight the relationship between exercise-induced idiopathic VAs (IVAs) and the long-term risk of cardiovascular death. The aim of this study was to assess the utility of heart rate variability (HRV) analysis as a noninvasive method for estimating autonomic nervous activity in children with exercise-induced IVAs. The study included 42 children with IVAs, who were divided into two groups: children with exercise-induced (precipitated or aggravated) IVAs and children with exercised-suppressed IVAs. Time-domain HRV parameters were analyzed from 24-h ambulatory electrocardiography recordings, and the majority of children underwent an exercise stress test using the McMaster protocol. The results of this study showed no significant changes in parasympathetic index, i.e., the square root of the mean of the sum of the squares of the differences between adjacent NN intervals (the length between two successive heartbeats) between the groups examined. On the other hand, we observed diminished time-domain values for the standard deviation of all adjacent NN intervals, as well as diminished time-domain values for standard deviation of the averages of NN intervals in all 5-min segments in the group of children with exercise-induced IVAs, implicating increased sympathetic activity in such individuals. HRV analysis could be a helpful diagnostic method, giving useful information regarding cardiac autonomic control in some children with exercise-induced IVAs.
- 14 November 2009
- Published by Springer Nature in Pediatric Cardiology
- Vol. 31 (2) , 188-194
Heart Rate Variability in Children with Exercise-Induced Idiopathic Ventricular Arrhythmias
Ventricular arrhythmias (VAs) are common pediatric rhythm disorders requiring comprehensive laboratory evaluation. Although usually idiopathic, implying a benign character and favorable prognosis, the initial clinical approach is still not established in all cases. Considering their prognostic significance, exercise-induced (precipitated or aggravated) VAs usually require additional diagnostics, treatment, and follow-up. A number of reports have presented experimental and clinical evidence that increased sympathetic activity can initiate, or at least facilitate, VAs. Recent data highlight the relationship between exercise-induced idiopathic VAs (IVAs) and the long-term risk of cardiovascular death. The aim of this study was to assess the utility of heart rate variability (HRV) analysis as a noninvasive method for estimating autonomic nervous activity in children with exercise-induced IVAs. The study included 42 children with IVAs, who were divided into two groups: children with exercise-induced (precipitated or aggravated) IVAs and children with exercised-suppressed IVAs. Time-domain HRV parameters were analyzed from 24-h ambulatory electrocardiography recordings, and the majority of children underwent an exercise stress test using the McMaster protocol. The results of this study showed no significant changes in parasympathetic index, i.e., the square root of the mean of the sum of the squares of the differences between adjacent NN intervals (the length between two successive heartbeats) between the groups examined. On the other hand, we observed diminished time-domain values for the standard deviation of all adjacent NN intervals, as well as diminished time-domain values for standard deviation of the averages of NN intervals in all 5-min segments in the group of children with exercise-induced IVAs, implicating increased sympathetic activity in such individuals. HRV analysis could be a helpful diagnostic method, giving useful information regarding cardiac autonomic control in some children with exercise-induced IVAs.